Retraction
miR-181a Ameliorates the Progression of Myasthenia Gravis by Regulating TRIM9
Paper Information
Record ID:
48666
Publication Date:
December 09, 2021
Retraction Date:
June 21, 2023
(2.4 years years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
- Concerns/Issues About Data
- Concerns/Issues about Results and/or Conclusions
- Concerns/Issues about Referencing/Attributions
- Concerns/Issues with Peer Review
- Informed/Patient Consent - None/Withdrawn
- Investigation by Journal/Publisher
- Investigation by Third Party
- Lack of IRB/IACUC Approval and/or Compliance
- Unreliable Results and/or Conclusions
Nature of Retraction:
Retraction
Retraction Notice:
10.1155/2023/9861015Citations (6)
6
Total Citations3
Post-Retraction(50.0%)
2
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
2
Within 1 year
0
After 2+ years
435
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Circ_0076490 silencing inhibits MAPK1 expression to decrease the proliferation and increase apoptosis of Jurkat cells by regulating miR-144-3p in myasthenia gravis
Qin Ye, Chengyao Gu, Wang Yan
Neurological Research
Published: Aug 2024
435 days after retraction
The intricate dance of non-coding RNAs in myasthenia gravis pathogenesis and treatment
Benqiao Wang, Ying Zhu, Dan Liu et al. (5 authors)
Frontiers in Immunology
Open Access
Published: Mar 2024
2 citations
2 citations
280 days after retraction
Paper citing miR-181a Ameliorates the Progression of Myasthenia...
Unknown Authors
Unknown Journal
Published: Nov 2023
160 days after retraction
Curcumol, a major terpenoid from Curcumae Rhizoma, attenuates human uterine leiomyoma cell development via the p38MAPK/NF-κB pathway
Yonghui Yu, Haojun Zhang, Fang Yang et al. (5 authors)
Journal of Ethnopharmacology
Published: Mar 2023
14 citations
14 citations
106 days before retraction
Retracted: miR-181a Ameliorates the Progression of Myasthenia Gravis by Regulating TRIM9
Evidence-Based Complementary and Alternative Medicine
Evidence-based Complementary and Alternative Medicine
Open Access
Published: Jan 2023
171 days before retraction
Quick Stats
Total Citations:
6
Years Since Retraction:
2.4 years
Open Access:
Yes
Last Checked:
Jul 24, 2025